PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Study demonstrates Bene PPS is unique, page-13

  1. 593 Posts.
    lightbulb Created with Sketch. 135
    Good thoughts. Like the market, I have set my expectations low and have mid 2026 as approval time should things go to plan. If we get a left field announcement like AA great, but I am not relying on it. I was thinking about that also, what is our TAM compared to NEU or TLX and what might our share price get to upon approval. $10 seemed a nice round number and a market cap of $3bn+ seemed realistic (assuming some further equity issued). However that is not based on any hard research and it might be worth looking into, something to pass the time anyway. Before delving into this, has anyone looked at TAM for these companies, would be great to hear your thoughts.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.